 |
|
|
| |
High Rates of SVR in Treatment-Experienced Patients With Genotype 1 HCV Infection and Cirrhosis After Treatment With Ledipasvir/Sofosbuvir and Vedroprevir With or Without Ribavirin for 8 Weeks
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 17 San Francisco
Eric Lawitz,1 Fred Poordad,1 Robert H. Hyland,2 Lin Liu,2 Hadas S. Dvory,2 Phillip S. Pang,2 Diana M. Brainard,2 Julio A. Gutierrez1
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX
2Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
